EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Breast Implant-Associated Anaplastic Large Cell Lymphoma: Where Hematology and Plastic Surgery Meet

Maria Magdalena Joks, Krystian Czernikiewicz, Łukasz Mazurkiewicz, Monika Joks, Andrzej Balcerzak, Renata Kroll-Balcerzak, Joanna Rupa-Matysek

Clinical Lymphoma Myeloma and Leukemia · 2024

DOI: 10.1016/j.clml.2024.05.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2024. Verfasst von Maria Magdalena Joks und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland. Hauptthemen laut MEDLINE: Lymphoma, Large-Cell, Anaplastic, Breast Implants. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast implant insertion for breast reconstruction or breast augmentation is a developing procedure, with high demand worldwide-being the second most common plastic surgery in the US as of 2022. Breast-implant-associated anaplastic large cell lymphoma (BIA-ALCL) is T-cell, non-Hodgkin lymphoma, typically CD30+, ALK-, presenting with fluid collection in the inner aspect of the peri-implant capsule in most patients, with the onset exceeding 1-year after implantation. The mean time between breast implant insertion and BIA-ALCL development is 7-10 years. The main risk factor is the use of textured implants because of their susceptibility to triggering local inflammation and immune stimulation finally leading to lymphoproliferation. Genetic predispositions to hereditary breast cancer increase the risk of disease development as well. BIA-ALCL seems to be underestimated in many countries and the initial symptom-seroma might be overlooked and misdiagnosed. Despite its rarity, the awareness of the disease should be improved among patients and medical professionals. This paper summarizes epidemiology, etiopathogenesis, differential diagnosis, and treatment-both surgical and hematological approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large-Cell, AnaplasticBreast ImplantsHumansFemaleBreast NeoplasmsSurgery, PlasticBreast ImplantationHematologyRisk Factors

Stichwörter der Autor:innen

Breast implant surgeryBreast implant-associated lymphomaBreast reconstructionImplantsT-cell Lymphoma

Autor:innen und Institutionen

  • Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
  • Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland. Electronic address: rupa.matysek@gmail.com.

Zitieren

APA

Joks, M. M., Czernikiewicz, K., Mazurkiewicz, Ł., Joks, M., Balcerzak, A., Kroll-Balcerzak, R., & Rupa-Matysek, J. (2024). Breast Implant-Associated Anaplastic Large Cell Lymphoma: Where Hematology and Plastic Surgery Meet. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2024.05.008

Vancouver

Joks MM, Czernikiewicz K, Mazurkiewicz Ł, Joks M, Balcerzak A, Kroll-Balcerzak R, et al. Breast Implant-Associated Anaplastic Large Cell Lymphoma: Where Hematology and Plastic Surgery Meet. Clinical Lymphoma Myeloma and Leukemia. 2024. doi:10.1016/j.clml.2024.05.008

BibTeX
@article{Joks2024,
  author = {Joks, Maria Magdalena and Czernikiewicz, Krystian and Mazurkiewicz, Łukasz and Joks, Monika and Balcerzak, Andrzej and Kroll-Balcerzak, Renata and Rupa-Matysek, Joanna},
  title = {Breast Implant-Associated Anaplastic Large Cell Lymphoma: Where Hematology and Plastic Surgery Meet},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2024},
  doi = {10.1016/j.clml.2024.05.008}
}
Kostenlos starten →